| Name | Title | Contact Details |
|---|
Human Longevity, Inc. (HLI) is a genomics and cell therapy company focused on extending the healthy, high performance human lifespan. Led by a world-class team of scientific and medical visionaries, HLI’s mission is to identify the therapeutically targetable mechanisms responsible for age-related human biological decline and to apply this intelligence to develop innovative solutions to interrupt or block those processes, meaningfully extending the human lifespan. We are building a database of genotype and phenotype information together with data mining infrastructure, on a scale that has not ever been done before. We are trying to tackle some of the most vexing diseases like cancer, heart disease and diabetes. We are blazing a new trail in science, medicine and research and we need people who, like us, want to change the world. Our founders, along with our scientific and medical teams are impatient for the healthcare of the future. That is why we are working to change the way medicine is practiced through our genomic-focused, preventive model. We are seeking world-class people who share our passion and want to play an integral role in executing the company’s vision. If you are dynamic, innovative, creative, intelligent, and resourceful, consider joining our quest to improve the state of healthcare in the world today.
ISI Interscience is a Troy, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ACT Services is a Saint Paul, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
biOasis Technologies Inc., an early stage biopharmaceutical company, engages in the research, development, and commercialization of technologies and products for the diagnosis and treatment of central nervous system diseases and disorders. The company develops Transcend program, a protein vector, which is a proprietary carrier for the transport of therapeutic agents across the blood brain barrier for treatment of a range of neurological, oncological, and infectious disease applications; and Cognitest, a proprietary in vitro diagnostic assay for Alzheimer’s disease. It has a collaborative research agreement with the University of British Columbia to assist the company in development of an enzyme linked immunosorbent assay to detect levels of p97 in blood for the purpose of evaluating the correlation between p97 and Alzheimer’s disease. The company was incorporated in 2006 and is headquartered in Vancouver, Canada.
Xpention Genetics Inc is a Conifer, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.